These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis. Østergaard C; Yieng-Kow RV; Knudsen JD; Frimodt-Møller N; Espersen F J Antimicrob Chemother; 2003 May; 51(5):1301-5. PubMed ID: 12697637 [TBL] [Abstract][Full Text] [Related]
24. [Evolution of gentamicin sensitivity in acute postpartum staphylococcal endocarditis]. Godeau P; Pechère JC; Sicard D Ann Med Interne (Paris); 1972 Mar; 123(3):225-8. PubMed ID: 4649708 [No Abstract] [Full Text] [Related]
25. Sodium fusidate in surgical wound infections. Schumer W; Abtahi H Am J Surg; 1968 Apr; 115(4):527-30. PubMed ID: 5184527 [No Abstract] [Full Text] [Related]
26. Fusidic acid resistance in Staphylococcus aureus isolates. Brown EM; Thomas P Lancet; 2002 Mar; 359(9308):803. PubMed ID: 11888633 [No Abstract] [Full Text] [Related]
27. Severe staphylococcal infection in an infant. Haider S Br J Clin Pract; 1973 Jan; 27(1):23-4. PubMed ID: 4685291 [No Abstract] [Full Text] [Related]
28. Intravenous fusidic acid ('Fucidin') in the management of severe staphylococcal infections: a review of 46 cases. Menday AP; Marsh BT Curr Med Res Opin; 1976; 4(2):132-8. PubMed ID: 1277881 [TBL] [Abstract][Full Text] [Related]
29. Introduction: fusidic acid enters the United States. Moellering RC; Corey GR; Grayson ML Clin Infect Dis; 2011 Jun; 52 Suppl 7():S467-8. PubMed ID: 21546622 [No Abstract] [Full Text] [Related]
31. Loss of antibiotic resistance in Staphylococcus aureus in vivo probably resulting from cloxacillin therapy. Lacey RW; Lewis E; Grinsted J J Med Microbiol; 1973 May; 6(2):191-9. PubMed ID: 4488468 [No Abstract] [Full Text] [Related]
32. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data. Rennie RP J Cutan Med Surg; 2006; 10(6):277-80. PubMed ID: 17241597 [TBL] [Abstract][Full Text] [Related]
33. Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections. Fernandes P Cold Spring Harb Perspect Med; 2016 Jan; 6(1):a025437. PubMed ID: 26729758 [TBL] [Abstract][Full Text] [Related]
34. Demonstration of in vitro antagonism between fusidic acid and quinolones. Ertek M; Yazgi H; Erol S; Altoparlak U J Int Med Res; 2002; 30(5):525-8. PubMed ID: 12449523 [TBL] [Abstract][Full Text] [Related]
35. [Pathogens of the puerperal infectious diseases during treatment with antibiotics]. Zak IR; Kupikova NN; Sokolov AK; Pankratova KV Akush Ginekol (Mosk); 1974 Mar; (3):29-32. PubMed ID: 4614678 [No Abstract] [Full Text] [Related]
36. [Sensitivity of staphylococci to macrolides and lincomycin]. Yourassowsky E; Prudhomme MR; Hawotte M Acta Clin Belg; 1968; 23(5):304-9. PubMed ID: 5737969 [No Abstract] [Full Text] [Related]
37. Methicillin-resistant staphylococci as an epidemiological indication for gentamicin therapy. Ericson C; Larsson S Acta Pathol Microbiol Scand B Microbiol Immunol; 1973; ():Suppl 241:65-8. PubMed ID: 4521609 [No Abstract] [Full Text] [Related]
38. A timely reminder about the concomitant use of fusidic acid with statins. Cowan R; Johnson PD; Urbancic K; Grayson ML Clin Infect Dis; 2013 Jul; 57(2):329-30. PubMed ID: 23588554 [No Abstract] [Full Text] [Related]
39. Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma. Clark SM; Loeffler A; Bond R J Antimicrob Chemother; 2015 Jul; 70(7):2048-52. PubMed ID: 25749003 [TBL] [Abstract][Full Text] [Related]